Entacapone/levodopa/carbidopa combination tablet: Stalevo.
@article{2003EntacaponelevodopacarbidopaCT, title={Entacapone/levodopa/carbidopa combination tablet: Stalevo.}, author={}, journal={Drugs in R\&D}, year={2003}, volume={4 5}, pages={ 310-1 } }
Entacapone (Comtess/Comtan) is Orion Pharma's original proprietary catechol-O-methyl transferase (COMT) inhibitor. Entacapone is able to slow down degradation of levodopa and improve the availability and efficacy of each levodopa dose, hence its use as a complement to levodopa/carbidopa in patients with Parkinson's disease. In order to simplify the daily dosing of these medications, Orion has developed an entacapone/levodopa/carbidopa combination tablet. Three tablet strengths are being…